Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab190144-100μg
|
100μg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$109.90
|
|
|
Ab190144-1mg
|
1mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$519.90
|
|
|
Ab190144-5mg
|
5mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$1,299.90
|
|
|
Ab190144-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$2,079.90
|
|
Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated
| Product Name | Azintuxizumab (anti-SLAMF7) - Primary antibody, specific to SLAMF7, Human IgG1 |
|---|---|
| Synonyms | 19A antibody19A24 protein antibody | CD 319 antibody | CD2 like receptor activating cytotoxic cells antibody | CD2 subset 1 antibody | CD319 antibody | CD319 antigen antibody | CRACC antibody | CS1 antibody | Membrane protein FOAP 12 antibody | Novel Ly9 |
| Specifications & Purity | Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA |
| Host species | Human |
| Specificity | SLAMF7 |
| Conjugation | Unconjugated |
| Grade | Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
| Product Description |
Azintuxizumab (anti-SLAMF7) is an anti-SLAMF7 human IgG1κ monoclonal antibody. Azintuxizumab (anti-SLAMF7) can be used in the synthesis of antibody-drug conjugate (ADC), Azintuxizumab vedotin.
|
| Isotype | Human IgG1 |
|---|---|
| Light Chain Type | kappa |
| SDS-PAGE | 145.32 kDa |
| Purification Method | Protein A purified |
| Concentration | See COA |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle. |
| CAS | 1826819-57-1 |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Azintuxizumab (anti-SLAMF7) (Ab190144) - Flow Cytometry
Flow Cytometry analysis of MM1.S cells labelling SLAMF7 with Azintuxizumab (anti-SLAMF7) (Ab190144) at 1×105 cell/well, with the EC₅₀ is 0.155 μg/mL.
Azintuxizumab (anti-SLAMF7) (Ab190144) - ELISA
Immobilized Recombinant Human SLAMF7/CRACC protein (rp181619) at 1.0 μg/mL can bind Azintuxizumab (anti-SLAMF7) (Ab190144) with the EC₅₀ of 343.9 ng/mL.
Azintuxizumab (anti-SLAMF7) (Ab190144) - SEC
The purity of Azintuxizumab (anti-SLAMF7) (Ab190144) is more than 95% verified by HPLC.
Starting at $59.90
Starting at $109.90